Clinical Trial Update: Immunomodulatory Therapy & VSA

View source ↗

Summary

A completed clinical trial update investigates an immunomodulatory therapy for vasospastic angina (VSA). The study is sponsored by Dao Wen Wang.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasospastic Angina

Snippet

Sponsor: Dao Wen Wang | Conditions: Vasospastic Angina | Status: COMPLETED